{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:53:59Z","timestamp":1788544439413,"version":"build-2803163510"},"reference-count":259,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroimaging Clinics of North America"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.nic.2005.09.009","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T15:10:36Z","timestamp":1168441836000},"page":"727-753","source":"Crossref","is-referenced-by-count":98,"title":["Pathophysiology of Alzheimer's Disease"],"prefix":"10.1016","volume":"15","author":[{"given":"Bruno P.","family":"Imbimbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Lombard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzio","family":"Pomara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nic.2005.09.009_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00002093-200110000-00002","article-title":"Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050","volume":"15","author":"Hebert","year":"2001","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.nic.2005.09.009_bib2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","article-title":"Alzheimer disease in the US population: prevalence estimates using the 2000 census","volume":"60","author":"Hebert","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib3","first-page":"1","article-title":"Deaths: preliminary data for 2003","volume":"53","author":"Hoyert","year":"2005","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.nic.2005.09.009_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-140-7-200404060-00008","article-title":"Survival after initial diagnosis of Alzheimer disease","volume":"140","author":"Larson","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nic.2005.09.009_bib5","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJMp058027","article-title":"Genetic factors in Alzheimer's disease","volume":"352","author":"Bird","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nic.2005.09.009_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.crvi.2004.10.013","article-title":"Molecular biology and genetics of Alzheimer's disease","volume":"328","author":"St George-Hyslop","year":"2004","journal-title":"C R Biol"},{"key":"10.1016\/j.nic.2005.09.009_bib7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.nic.2005.09.009_bib8","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a novel gene bearing missense mutations in early onset familial Alzheimer disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.nic.2005.09.009_bib9","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer's disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.nic.2005.09.009_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1750-3639.2001.tb00376.x","article-title":"Key factors in Alzheimer's disease: \u03b2-amyloid precursor protein processing, metabolism and intraneuronal transport","volume":"11","author":"Bayer","year":"2001","journal-title":"Brain Pathol"},{"key":"10.1016\/j.nic.2005.09.009_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0197-0186(99)00125-4","article-title":"What the evolution of the amyloid protein precursor supergene family tells us about its function","volume":"36","author":"Coulson","year":"2000","journal-title":"Neurochem Int"},{"key":"10.1016\/j.nic.2005.09.009_bib12","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1083\/jcb.153.7.1403","article-title":"The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement","volume":"153","author":"Sabo","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nic.2005.09.009_bib13","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1046\/j.1471-4159.2000.0742331.x","article-title":"A monoclonal antibody to amyloid precursor protein induces neuronal apoptosis","volume":"74","author":"Rohn","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.nic.2005.09.009_bib14","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1242\/dev.01103","article-title":"Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone","volume":"131","author":"Caille","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.nic.2005.09.009_bib15","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/hmg\/6.12.2087","article-title":"A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A\u03b242(43)","volume":"6","author":"Eckman","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nic.2005.09.009_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10048-005-0211-x","article-title":"Novel mutations and repeated findings of mutations in familial Alzheimer disease","volume":"6","author":"Finckh","year":"2005","journal-title":"Neurogenetics"},{"key":"10.1016\/j.nic.2005.09.009_bib17","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nn0901-887","article-title":"The \u2018Arctic\u2019 APP mutation (E693G) causes Alzheimer's disease by enhanced A\u03b2 protofibril formation","volume":"4","author":"Nilsberth","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm1123","article-title":"Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation","volume":"10","author":"Cheng","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.nic.2005.09.009_bib19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/jnnp.2003.010611","article-title":"Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer's disease","volume":"75","author":"Wakutani","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nic.2005.09.009_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/JAD-2005-7207","article-title":"Novel mutations introduced at the \u03b2-site of amyloid \u03b2 protein precursor enhance the production of amyloid \u03b2 peptide by BACE1 in vitro and in cells","volume":"7","author":"Shi","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nic.2005.09.009_bib21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid \u03b2-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.nic.2005.09.009_bib22","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1523\/JNEUROSCI.0364-05.2005","article-title":"Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein","volume":"25","author":"Berezovska","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3233\/JAD-2004-6503","article-title":"Pathological and clinical heterogeneity of presenilin 1 gene mutations","volume":"6","author":"Menendez","year":"2004","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nic.2005.09.009_bib24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.20083","article-title":"A novel presenilin 1 mutation associated with Pick's disease but not \u03b2-amyloid plaques","volume":"55","author":"Dermaut","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib25","first-page":"256","article-title":"Novel PS1 mutation in a Bavarian kindred with familial Alzheimer disease","volume":"18","author":"Klunemann","year":"2004","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.nic.2005.09.009_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-2005-7204","article-title":"One novel presenilin-1 gene mutation in a Chinese pedigree of familial Alzheimer's disease","volume":"7","author":"Jia","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nic.2005.09.009_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1529-8817.2004.00110.x","article-title":"Molecular genetics of late-onset Alzheimer's disease","volume":"68","author":"Kamboh","year":"2004","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.nic.2005.09.009_bib28","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1093\/hmg\/ddh077","article-title":"Alzheimer's disease: one disorder, too many genes?","volume":"13","author":"Bertram","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nic.2005.09.009_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.nic.2005.09.009_bib30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.nic.2005.09.009_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/gepi.1370090302","article-title":"Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world","volume":"9","author":"Gerdes","year":"1992","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.nic.2005.09.009_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.nic.2005.09.009_bib33","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ana.410340527","article-title":"The apolipoprotein \u025b4 allele in patients with Alzheimer's disease","volume":"34","author":"Mayeux","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1126\/science.8290965","article-title":"Alzheimer's disease and possible gene interaction","volume":"263","author":"St George-Hyslop","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.nic.2005.09.009_bib35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/archneur.62.2.192","article-title":"Defining molecular targets to prevent Alzheimer disease","volume":"62","author":"Selkoe","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib36","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"issue":"Pt. 2","key":"10.1016\/j.nic.2005.09.009_bib37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/0264-6021:3480359","article-title":"Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides","volume":"348","author":"Tokuda","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.nic.2005.09.009_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0304-3940(92)90444-C","article-title":"Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid","volume":"135","author":"Wisniewski","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.nic.2005.09.009_bib39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0197-0186(00)00128-5","article-title":"Effects of apolipoprotein E (apoE) isoforms, \u03b2-amyloid (A\u03b2) and apoE\/A\u03b2 complexes on protein kinase C-\u03b1 (PKC-\u03b1) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts","volume":"38","author":"Cedazo-Minguez","year":"2001","journal-title":"Neurochem Int"},{"key":"10.1016\/j.nic.2005.09.009_bib40","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nic.2005.09.009_bib41","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1126\/science.290.5500.2303","article-title":"Linkage of plasma A\u03b242 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees","volume":"290","author":"Ertekin-Taner","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.nic.2005.09.009_bib42","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1126\/science.290.5500.2304","article-title":"Susceptibility locus for Alzheimer's disease on chromosome 10","volume":"290","author":"Myers","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.nic.2005.09.009_bib43","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1093\/hmg\/ddg343","article-title":"Fine mapping of the \u03b1-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees","volume":"12","author":"Ertekin-Taner","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nic.2005.09.009_bib44","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","article-title":"Neurons regulate extracellular levels of amyloid \u03b2-protein via proteolysis by insulin-degrading enzyme","volume":"20","author":"Vekrellis","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/humu.20016","article-title":"Genetic variants in a haplotype block spanning IDE are significantly associated with plasma A\u03b242 levels and risk for Alzheimer disease","volume":"23","author":"Ertekin-Taner","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nic.2005.09.009_bib46","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/hmg\/ddi041","article-title":"Elevated amyloid \u03b2 protein (A\u03b242) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene","volume":"14","author":"Ertekin-Taner","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nic.2005.09.009_bib47","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1086\/302828","article-title":"Am. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity","volume":"66","author":"Scott","year":"2000","journal-title":"J Hum Genet"},{"key":"10.1016\/j.nic.2005.09.009_bib48","first-page":"2275","article-title":"Hum. The transcriptional factor LBP-1c\/CP2\/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease","volume":"9","author":"Lambert","year":"2000","journal-title":"Mol Genet"},{"key":"10.1016\/j.nic.2005.09.009_bib49","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1046\/j.1471-4159.1999.0731393.x","article-title":"\u03b12-Macroglobulin enhances the clearance of endogenous soluble \u03b2-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons","volume":"73","author":"Qiu","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.nic.2005.09.009_bib50","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1212\/WNL.54.2.433","article-title":"Lack of association of the \u03b12-macroglobulin locus on chromosome 12 in AD","volume":"54","author":"Gibson","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2005.09.009_bib51","first-page":"1","article-title":"Neither the tumor necrosis factor alpha-308 A\/G polymorphism nor the \u03b12-macroglobulin polymorphism was associated with late-onset Alzheimer's disease in the Chinese population","volume":"31","author":"Zhang","year":"2004","journal-title":"Yi Chuan Xue Bao"},{"key":"10.1016\/j.nic.2005.09.009_bib52","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid \u03b2-peptide interaction mediates differential brain efflux of A\u03b2 isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nic.2005.09.009_bib53","doi-asserted-by":"crossref","first-page":"17777","DOI":"10.1074\/jbc.M414248200","article-title":"The low density lipoprotein receptor-related protein (LRP) is a novel \u03b2-secretase (BACE1) substrate","volume":"280","author":"von Arnim","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nic.2005.09.009_bib54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neures.2004.06.001","article-title":"Genetic and functional characteristics of the human in vivo LRP1\/A2MR receptor suggested as a risk marker for Alzheimer's disease and other complex (degenerative) diseases","volume":"50","author":"Glaser","year":"2004","journal-title":"Neurosci Res"},{"key":"10.1016\/j.nic.2005.09.009_bib55","doi-asserted-by":"crossref","first-page":"15688","DOI":"10.1073\/pnas.0403535101","article-title":"Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family","volume":"101","author":"Li","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nic.2005.09.009_bib56","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1471-4159.1993.tb13420.x","article-title":"Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's \u03b2-amyloid precursor protein","volume":"60","author":"Schulze","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.nic.2005.09.009_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0167-4838(00)00057-1","article-title":"Glutamine synthetase, hemoglobin \u03b1-chain, and macrophage migration inhibitory factor binding to amyloid \u03b2-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation","volume":"1479","author":"Oyama","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nic.2005.09.009_bib58","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/hmg\/9.6.979","article-title":"Untangling tau-related dementia","volume":"9","author":"Heutink","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nic.2005.09.009_bib59","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0925-4439(00)00037-5","article-title":"Biochim. Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease","volume":"1502","author":"Goedert","year":"2000","journal-title":"Biophys Acta"},{"key":"10.1016\/j.nic.2005.09.009_bib60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbadis.2004.08.007","article-title":"Mutations causing neurodegenerative tauopathies","volume":"1739","author":"Goedert","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nic.2005.09.009_bib61","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbadis.2004.08.009","article-title":"Regulation of tau isoform expression and dementia","volume":"1739","author":"D'Souza","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nic.2005.09.009_bib62","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nic.2005.09.009_bib63","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neuroscience.2004.09.029","article-title":"Characterization of a double (amyloid precursor protein-\u03c4) transgenic: \u03c4 phosphorylation and aggregation","volume":"130","author":"Perez","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.nic.2005.09.009_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2002.00855.x","article-title":"\u03b2-Amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?","volume":"81","author":"Carson","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.nic.2005.09.009_bib65","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/jnnp.2004.036574","article-title":"Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients","volume":"75","author":"Helisalmi","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nic.2005.09.009_bib66","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/gerona\/60.3.301","article-title":"Mutation screening and association study of the neprilysin gene in sporadic Alzheimer's disease in chinese persons","volume":"60","author":"Shi","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.nic.2005.09.009_bib67","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMoa042765","article-title":"Family-based association between Alzheimer's disease and variants in UBQLN1","volume":"352","author":"Bertram","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nic.2005.09.009_bib68","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1385\/JMN:25:2:127","article-title":"Genetic association of BACE1 gene polymorphism C786G with late-onset Alzheimer's disease in Chinese","volume":"25","author":"Kan","year":"2005","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib69","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1523\/JNEUROSCI.4998-04.2005","article-title":"\u03b2-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor \u03b1 and NMDA receptors","volume":"25","author":"Floden","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000085067","article-title":"Heat shock protein 70 and tumor necrosis factor-\u03b1 in Taiwanese patients with dementia","volume":"20","author":"Fung","year":"2005","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.nic.2005.09.009_bib71","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ana.10414","article-title":"Plasma and cerebrospinal fluid \u03b11-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment","volume":"53","author":"DeKosky","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib72","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ng0895-486","article-title":"APOE\u025b4-associated Alzheimer's disease risk is modified by \u03b11-antichymotrypsin polymorphism","volume":"10","author":"Kamboh","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.nic.2005.09.009_bib73","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1212\/WNL.47.6.1575","article-title":"Lack of association between \u03b11-antichymotrypsin polymorphism, Alzheimer's disease, and allele \u025b4 of apolipoprotein E","volume":"47","author":"Muller","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2005.09.009_bib74","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.neurobiolaging.2004.05.001","article-title":"A new promoter polymorphism in the \u03b1-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease","volume":"26","author":"Licastro","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nic.2005.09.009_bib75","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00019052-200412000-00012","article-title":"Head injury and dementia","volume":"17","author":"Jellinger","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib76","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/00005072-199909000-00008","article-title":"Accumulation of amyloid \u03b2 and \u03c4 and the formation of neurofilament inclusions following diffuse brain injury in the pig","volume":"58","author":"Smith","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib77","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0379-0738(00)00335-2","article-title":"Brain injury after survived gunshot to the head: reactive alterations at sites remote from the missile track","volume":"115","author":"Oehmichen","year":"2001","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.nic.2005.09.009_bib78","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1089\/neu.2000.17.1041","article-title":"Upregulation of neuronal amyloid precursor protein (APP) and APP mRNA following magnesium sulphate (MgSO4) therapy in traumatic brain injury","volume":"17","author":"Van Den Heuvel","year":"2000","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.nic.2005.09.009_bib79","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.54.6.1316","article-title":"Head injury and the risk of AD in the MIRAGE study","volume":"54","author":"Guo","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2005.09.009_bib80","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1212\/WNL.53.9.1959","article-title":"Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam Study","volume":"53","author":"Mehta","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2005.09.009_bib81","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/jnnp.74.7.857","article-title":"Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication","volume":"74","author":"Fleminger","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nic.2005.09.009_bib82","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/1097-0029(20000815)50:4<278::AID-JEMT5>3.0.CO;2-T","article-title":"Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology","volume":"50","author":"Baum","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.nic.2005.09.009_bib83","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E \u025b4 allele, and Alzheimer's disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.nic.2005.09.009_bib84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000026249","article-title":"Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study","volume":"19","author":"Bonarek","year":"2000","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.nic.2005.09.009_bib85","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1212\/WNL.53.3.517","article-title":"APOE genotype, plasma lipids, lipoproteins, and AD in community elderly","volume":"53","author":"Romas","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2005.09.009_bib86","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1212\/01.WNL.0000161870.78572.A5","article-title":"High total cholesterol levels in late life associated with a reduced risk of dementia","volume":"64","author":"Mielke","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2005.09.009_bib87","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib88","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1212\/01.WNL.0000142963.90204.58","article-title":"Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study","volume":"63","author":"Li","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2005.09.009_bib89","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1074\/jbc.271.8.4436","article-title":"Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein","volume":"271","author":"Bodovitz","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nic.2005.09.009_bib90","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of \u03b2-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nic.2005.09.009_bib91","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1073\/pnas.081612998","article-title":"Low cholesterol stimulates the non amyloidogenic pathway by its effect on the \u03b1-secretase ADAM 10","volume":"98","author":"Kojro","year":"2001","journal-title":"Proc Natl Sci USA"},{"key":"10.1016\/j.nic.2005.09.009_bib92","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1371\/journal.pmed.0020018","article-title":"Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK","volume":"2","author":"Pedrini","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.nic.2005.09.009_bib93","doi-asserted-by":"crossref","first-page":"18755","DOI":"10.1074\/jbc.M413895200","article-title":"Statins cause intracellular accumulation of amyloid precursor protein, \u03b2-secretase-cleaved fragments, and amyloid \u03b2-peptide via an isoprenoid-dependent mechanism","volume":"280","author":"Cole","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nic.2005.09.009_bib94","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1194\/jlr.M400333-JLR200","article-title":"Association of active \u03b3-secretase complex with lipid rafts","volume":"46","author":"Urano","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.nic.2005.09.009_bib95","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/exnr.1994.1044","article-title":"Induction of Alzheimer-like \u03b2-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol","volume":"126","author":"Sparks","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib96","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","article-title":"Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nic.2005.09.009_bib97","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1006\/nbdi.2001.0422","article-title":"A cholesterol-lowering drug reduces \u03b2-amyloid pathology in a transgenic mouse model of Alzheimer's disease","volume":"8","author":"Refolo","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nic.2005.09.009_bib98","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.nic.2005.09.009_bib99","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.nic.2005.09.009_bib100","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.62.5.753","article-title":"Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results","volume":"62","author":"Sparks","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib101","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000051275","article-title":"Homocysteine and cognitive decline in healthy elderly","volume":"12","author":"McCaddon","year":"2001","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.nic.2005.09.009_bib102","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1046\/j.1532-5415.2002.50614.x","article-title":"Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people","volume":"50","author":"Budge","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.nic.2005.09.009_bib103","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1212\/WNL.58.10.1539","article-title":"Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals","volume":"58","author":"Sachdev","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2005.09.009_bib104","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.amjmed.2004.08.019","article-title":"Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging","volume":"118","author":"Kado","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.nic.2005.09.009_bib105","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/ajcn\/81.5.1155","article-title":"Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study","volume":"81","author":"Lewerin","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nic.2005.09.009_bib106","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jns.2004.08.011","article-title":"Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel","volume":"227","author":"Mizrahi","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nic.2005.09.009_bib107","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1212\/01.WNL.0000129504.60409.88","article-title":"Plasma homocysteine levels and risk of Alzheimer disease","volume":"62","author":"Luchsinger","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2005.09.009_bib108","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.archger.2004.07.005","article-title":"Vitamin B12, folate, homocysteine and dementia: are they really related?","volume":"40","author":"Ariogul","year":"2005","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.nic.2005.09.009_bib109","first-page":"CD004514","article-title":"Folic acid with or without vitamin B12 for cognition and dementia","volume":"4","author":"Malouf","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nic.2005.09.009_bib110","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jnr.20514","article-title":"Homocysteic acid induces intraneuronal accumulation of neurotoxic A\u03b242: implications for the pathogenesis of Alzheimer's disease","volume":"80","author":"Hasegawa","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nic.2005.09.009_bib111","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-277X.2004.00532.x","article-title":"A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly","volume":"17","author":"Ellinson","year":"2004","journal-title":"J Hum Nutr Diet"},{"key":"10.1016\/j.nic.2005.09.009_bib112","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4067\/S0716-97602004000200003","article-title":"Risk of dementia and alcohol and wine consumption: a review of recent results","volume":"37","author":"Letenneur","year":"2004","journal-title":"Biol Res"},{"key":"10.1016\/j.nic.2005.09.009_bib113","first-page":"185","article-title":"Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area","volume":"153","author":"Orgogozo","year":"1997","journal-title":"Rev Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib114","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(02)07493-7","article-title":"Alcohol consumption and risk of dementia: the Rotterdam Study","volume":"359","author":"Ruitenberg","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.nic.2005.09.009_bib115","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0895-4356(02)00462-6","article-title":"Alcohol consumption and incidence of dementia in a community sample aged 75 years and older","volume":"5","author":"Huang","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.nic.2005.09.009_bib116","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1532-5415.2004.52159.x","article-title":"Alcohol intake and risk of dementia","volume":"52","author":"Luchsinger","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.nic.2005.09.009_bib117","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1212\/01.WNL.0000058751.43033.4D","article-title":"Comparison of Alzheimer's disease risk factors in white and African American families","volume":"60","author":"Bachman","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2005.09.009_bib118","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2004.09.007","article-title":"Lipids, diet and Alzheimer disease: an extended summary","volume":"226","author":"Petot","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nic.2005.09.009_bib119","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1001\/jama.287.24.3223","article-title":"Dietary intake of antioxidants and risk of Alzheimer disease","volume":"287","author":"Engelhart","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.nic.2005.09.009_bib120","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1001\/jama.287.24.3230","article-title":"Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study","volume":"287","author":"Morris","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.nic.2005.09.009_bib121","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A controlled trial of selegiline, \u03b1-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"336","author":"Sano","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nic.2005.09.009_bib122","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nic.2005.09.009_bib123","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2165\/00023210-200418120-00005","article-title":"Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders","volume":"18","author":"Berman","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nic.2005.09.009_bib124","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1474-4422(04)00878-6","article-title":"Dietary factors and Alzheimer's disease","volume":"3","author":"Luchsinger","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nic.2005.09.009_bib126","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nic.2005.09.009_bib127","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nic.2005.09.009_bib128","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nic.2005.09.009_bib129","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","article-title":"The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor","volume":"325","author":"Kang","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.nic.2005.09.009_bib130","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.2111584","article-title":"Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage. Dutch type","volume":"248","author":"Levy","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.nic.2005.09.009_bib131","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/0006-291X(91)91706-I","article-title":"Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation","volume":"179","author":"Wisniewski","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nic.2005.09.009_bib132","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","article-title":"Mutation of the \u03b2-amyloid precursor protein in familial Alzheimer's disease increases \u03b2-protein production","volume":"360","author":"Citron","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.nic.2005.09.009_bib133","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1126\/science.8424174","article-title":"Release of excess amyloid \u03b2 protein from a mutant amyloid \u03b2 protein precursor","volume":"259","author":"Cai","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.nic.2005.09.009_bib134","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.8191290","article-title":"1994. An increased percentage of long amyloid \u03b2 protein secreted by familial amyloid b protein precursor (\u03b2APP717) mutants","volume":"264","author":"Suzuki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.nic.2005.09.009_bib135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1197-263","article-title":"Lack of apolipoprotein E dramatically reduces amyloid \u03b2-peptide deposition","volume":"17","author":"Bales","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.nic.2005.09.009_bib136","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/1565","article-title":"Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to \u03c4","volume":"1","author":"Hardy","year":"1998","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib137","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced neurofibrillary degeneration in transgenic mice expressing mutant \u03c4 and APP","volume":"293","author":"Lewis","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nic.2005.09.009_bib138","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1126\/science.290.5500.2302","article-title":"Evidence for genetic linkage of Alzheimer's disease to chromosome 10q","volume":"290","author":"Bertram","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.nic.2005.09.009_bib139","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A\u03b2 and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nic.2005.09.009_bib140","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0140-6736(05)79757-9","article-title":"\u03b2-42 deposition precedes other changes in PS-1 Alzheimer's disease","volume":"352","author":"Lippa","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.nic.2005.09.009_bib141","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","article-title":"Correlation between elevated levels of amyloid \u03b2-peptide in the brain and cognitive decline","volume":"283","author":"Naslund","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.nic.2005.09.009_bib142","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.410380413","article-title":"Reduction of \u03b2-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease","volume":"38","author":"Motter","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib143","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A","article-title":"Plasma amyloid \u03b2-peptide 1\u201342 and incipient Alzheimer's disease","volume":"46","author":"Mayeux","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib144","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1212\/01.WNL.0000137040.64252.ED","article-title":"Plasma levels of amyloid \u03b2-protein 42 are increased in women with mild cognitive impairment","volume":"63","author":"Assini","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2005.09.009_bib145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nm0103-3","article-title":"Elevated \u03b2-secretase expression and enzymatic activity detected in sporadic Alzheimer disease","volume":"9","author":"Yang","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.nic.2005.09.009_bib146","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1073\/pnas.0205689101","article-title":"Amyloid \u03b2 peptide load is correlated with increased \u03b2-secretase activity in sporadic Alzheimer's disease patients","volume":"101","author":"Li","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nic.2005.09.009_bib147","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from A\u03b21\u201342 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nic.2005.09.009_bib148","doi-asserted-by":"crossref","first-page":"8876","DOI":"10.1523\/JNEUROSCI.19-20-08876.1999","article-title":"Protofibrillar intermediates of amyloid \u03b2-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons","volume":"19","author":"Hartley","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib149","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1074\/jbc.271.8.4077","article-title":"Water-soluble A\u03b2 (N-40, N-42) oligomers in normal and Alzheimer disease brains","volume":"271","author":"Kuo","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nic.2005.09.009_bib150","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1523\/JNEUROSCI.5167-03.2004","article-title":"Oligomerization of Alzheimer's \u03b2-amyloid within processes and synapses of cultured neurons and brain","volume":"24","author":"Takahashi","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib151","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1096\/fj.01-0987fje","article-title":"Selective neuronal degeneration induced by soluble oligomeric amyloid \u03b2 protein","volume":"17","author":"Kim","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.nic.2005.09.009_bib152","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.nic.2005.09.009_bib153","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nn1335","article-title":"Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches","volume":"7","author":"Tsai","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib154","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/00001756-199906030-00014","article-title":"The role of cholesterol in the biosynthesis of \u03b2-amyloid","volume":"10","author":"Frears","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.nic.2005.09.009_bib155","doi-asserted-by":"crossref","first-page":"16576","DOI":"10.1074\/jbc.273.26.16576","article-title":"Modulation of secreted \u03b2-amyloid precursor protein and amyloid \u03b2-peptide in brain by cholesterol","volume":"273","author":"Howland","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nic.2005.09.009_bib156","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1471-4159.2004.02737.x","article-title":"A modified \u03b2-amyloid hypothesis: intraneuronal accumulation of the \u03b2-amyloid peptide\u2014the first step of a fatal cascade","volume":"91","author":"Wirths","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.nic.2005.09.009_bib157","doi-asserted-by":"crossref","first-page":"9513","DOI":"10.1073\/pnas.90.20.9513","article-title":"Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and p roduce intracellular \u03b2-amyloid or A4 peptides","volume":"90","author":"Wertkin","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nic.2005.09.009_bib158","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nm0997-1016","article-title":"Distinct sites of intracellular production for Alzheimer's disease A\u03b240\/42 amyloid peptides","volume":"3","author":"Hartmann","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.nic.2005.09.009_bib159","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1073\/pnas.96.2.742","article-title":"Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer \u03b2-amyloid peptides","volume":"96","author":"Greenfield","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nic.2005.09.009_bib160","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1021\/bi001048s","article-title":"The oligomerization of amyloid b-protein begins intracellularly in cells derived from human brain","volume":"39","author":"Walsh","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.nic.2005.09.009_bib161","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","article-title":"Intraneuronal A\u03b242 accumulation in human brain","volume":"156","author":"Gouras","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nic.2005.09.009_bib162","first-page":"823","article-title":"Intra- and extracellular A\u03b2 and PHF in clinically evaluated cases of Alzheimer's disease","volume":"19","author":"Fernandez-Vizarra","year":"2004","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.nic.2005.09.009_bib163","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.0953-816X.2003.03135.x","article-title":"Enhanced generation of intracellular A\u03b242 amyloid peptide by mutation of presenilins PS1 and PS2","volume":"19","author":"Takeda","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib164","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1021\/bi0267590","article-title":"Distinct mechanisms by mutant presenilin 1 and 2 leading to increased intracellular levels of amyloid \u03b2-protein 42 in Chinese hamster ovary cells","volume":"42","author":"Qi","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.nic.2005.09.009_bib165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0304-3940(01)01876-6","article-title":"Intraneuronal Ab accumulation precedes plaque formation in \u03b2-amyloid precursor protein and presenilin-1 double-transgenic mice","volume":"306","author":"Wirths","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.nic.2005.09.009_bib166","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0014-4886(03)00252-8","article-title":"Time sequence of maturation of dystrophic neurites associated with A\u03b2 deposits in APP\/PS1 transgenic mice","volume":"184","author":"Blanchard","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib167","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1750-3639.2002.tb00442.x","article-title":"Intraneuronal APP\/Ab trafficking and plaque formation in b-amyloid precursor protein and presenilin-1 transgenic mice","volume":"12","author":"Wirths","year":"2002","journal-title":"Brain Pathol"},{"key":"10.1016\/j.nic.2005.09.009_bib168","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00001756-200301200-00023","article-title":"Early intraneuronal Ab deposition in the hippocampus of APP transgenic mice","volume":"14","author":"Shie","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.nic.2005.09.009_bib169","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1073\/pnas.89.16.7437","article-title":"Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4\/\u03b2 protein","volume":"89","author":"Knauer","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nic.2005.09.009_bib170","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-8993(96)01262-0","article-title":"Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, A\u03b21\u201342, in differentiated PC12 cells","volume":"746","author":"Burdick","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.nic.2005.09.009_bib171","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-2001-3208","article-title":"Apoptotic neurons in Alzheimer's disease frequently show intracellular A\u03b242 labeling","volume":"3","author":"Chui","year":"2001","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nic.2005.09.009_bib172","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng0195-21","article-title":"The Alzheimer's A\u03b2 peptide induces neurodegeneration and apoptotic cell death in transgenic mice","volume":"9","author":"LaFerla","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.nic.2005.09.009_bib173","doi-asserted-by":"crossref","first-page":"15666","DOI":"10.1074\/jbc.M200887200","article-title":"Intracellular amyloid-\u03b21\u201342, but not extracellular soluble amyloid-\u03b2 peptides, induces neuronal apoptosis","volume":"277","author":"Kienlen-Campard","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nic.2005.09.009_bib174","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00001756-200001170-00033","article-title":"Selective increase in cellular A\u03b242 is related to apoptosis but not necrosis","volume":"11","author":"Ohyagi","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.nic.2005.09.009_bib175","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1021\/bi000169p","article-title":"Oxidative stress induces intracellular accumulation of amyloid \u03b2-protein (A\u03b2) in human neuroblastoma cells","volume":"39","author":"Misonou","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.nic.2005.09.009_bib176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tins.2003.10.008","article-title":"Living with the enemy: a physiological role for the \u03b2-amyloid peptide","volume":"27","author":"Esteban","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib177","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/359325a0","article-title":"Isolation and quantification of soluble Alzheimer's \u03b2-peptide from biological fluids","volume":"359","author":"Seubert","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.nic.2005.09.009_bib178","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0006-8993(02)03547-3","article-title":"Modulation of Ca2 + channel currents in primary cultures of rat cortical neurones by amyloid \u03b2 protein (1\u201340) is dependent on solubility status","volume":"956","author":"Ramsden","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.nic.2005.09.009_bib179","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nic.2005.09.009_bib180","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1523\/JNEUROSCI.23-13-05531.2003","article-title":"The production of amyloid \u03b2 peptide is a critical requirement for the viability of central neurons","volume":"23","author":"Plant","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib181","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1750-3639.2005.tb00101.x","article-title":"Intracellular and extracellular A\u03b2, a tale of two neuropathologies","volume":"15","author":"Cuello","year":"2005","journal-title":"Brain Pathol"},{"key":"10.1016\/j.nic.2005.09.009_bib182","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0197-4580(97)00066-3","article-title":"The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies","volume":"18","author":"Hyman","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nic.2005.09.009_bib183","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.nic.2005.09.009_bib184","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nic.2005.09.009_bib185","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of A\u03b2 amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib186","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7085","article-title":"The levels of soluble versus insoluble brain A\u03b2 distinguish Alzheimer's disease from normal and pathologic aging","volume":"158","author":"Wang","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib187","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F","article-title":"Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations","volume":"48","author":"Houlden","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib188","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0896-6273(04)00533-1","article-title":"Clearance of Alzheimer's Abeta peptide: the many roads to perdition","volume":"43","author":"Tanzi","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nic.2005.09.009_bib189","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1471-4159.2004.02385.x","article-title":"Clearing amyloid through the blood-brain barrier","volume":"89","author":"Zlokovic","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.nic.2005.09.009_bib190","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-\u03b21\u201340 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nic.2005.09.009_bib191","unstructured":"Herz 2003"},{"issue":"11, Suppl 1","key":"10.1016\/j.nic.2005.09.009_bib192","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/01.STR.0000143452.85382.d1","article-title":"RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid b-peptide clearance through transport across the blood-brain barrier","volume":"35","author":"Deane","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.nic.2005.09.009_bib193","doi-asserted-by":"crossref","first-page":"9298","DOI":"10.1523\/JNEUROSCI.22-21-09298.2002","article-title":"Increased extracellular amyloid deposition and neurodegeneration in human amyloid precursor protein transgenic mice deficient in receptor-associated protein","volume":"22","author":"Van Uden","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib194","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/76216","article-title":"Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis","volume":"6","author":"Yan","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.nic.2005.09.009_bib195","first-page":"167","article-title":"RAGE-A\u03b2 interactions in the pathophysiology of Alzheimer's disease","volume":"12","author":"Yan","year":"1998","journal-title":"Restor Neurol Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib196","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-\u03b2 peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.nic.2005.09.009_bib197","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1038\/sj.emboj.7600415","article-title":"RAGE potentiates A\u03b2-induced perturbation of neuronal function in transgenic mice","volume":"23","author":"Arancio","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.nic.2005.09.009_bib198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1332.001","article-title":"Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegeneration","volume":"1035","author":"Turner","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nic.2005.09.009_bib199","first-page":"149","article-title":"Insulin-degrading enzyme","volume":"19","author":"Authier","year":"1996","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.nic.2005.09.009_bib200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0896-6273(01)00475-5","article-title":"Clearing the brain's amyloid cobwebs","volume":"32","author":"Selkoe","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.nic.2005.09.009_bib201","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid \u03b2-protein, and the \u03b2-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nic.2005.09.009_bib202","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of \u03b2-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death","volume":"40","author":"Leissring","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nic.2005.09.009_bib203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1385\/JMN:23:3:213","article-title":"Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's disease","volume":"23","author":"Edland","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib204","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K","article-title":"The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function","volume":"23","author":"Turner","year":"2001","journal-title":"Bioessays"},{"key":"10.1016\/j.nic.2005.09.009_bib205","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/oxfordjournals.jbchem.a003040","article-title":"Clearance of extracellular and cell-associated amyloid \u03b2 peptide through viral expression of neprilysin in primary neurons","volume":"30","author":"Hama","year":"2001","journal-title":"J Biochem (Tokyo)"},{"key":"10.1016\/j.nic.2005.09.009_bib206","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1059946","article-title":"Metabolic regulation of brain A\u03b2 by neprilysin","volume":"292","author":"Iwata","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nic.2005.09.009_bib207","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0014-5793(04)00169-3","article-title":"Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease","volume":"562","author":"Mohajeri","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nic.2005.09.009_bib208","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1523\/JNEUROSCI.23-06-01992.2003","article-title":"Neprilysin gene transfer reduces human amyloid pathology in transgenic mice","volume":"23","author":"Marr","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib209","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbrc.2003.09.003","article-title":"Oxidized neprilysin in aging and Alzheimer's disease brains","volume":"310","author":"Wang","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nic.2005.09.009_bib210","doi-asserted-by":"crossref","first-page":"24540","DOI":"10.1074\/jbc.M007579200","article-title":"Degradation of the Alzheimer's amyloid b peptide by endothelin-converting enzyme","volume":"276","author":"Eckman","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nic.2005.09.009_bib211","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1074\/jbc.C200642200","article-title":"Alzheimer's disease \u03b2-amyloid peptide is increased in mice deficient in endothelin-converting enzyme","volume":"278","author":"Eckman","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nic.2005.09.009_bib212","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/sj.mp.4001584","article-title":"Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease","volume":"9","author":"Funalot","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.nic.2005.09.009_bib213","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease","volume":"60","author":"Nunomura","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib214","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1471-4914(01)02173-6","article-title":"Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid \u03b2-peptide","volume":"7","author":"Butterfield","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.nic.2005.09.009_bib215","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.nic.2005.09.009_bib216","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jocn.2003.12.007","article-title":"Alzheimer's disease pathogenesis and therapeutic interventions","volume":"11","author":"Parihar","year":"2004","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib217","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/382120b0","article-title":"Oxidative damage in Alzheimer's","volume":"382","author":"Smith","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.nic.2005.09.009_bib218","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0006-8993(01)02758-5","article-title":"Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology","volume":"913","author":"Luth","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.nic.2005.09.009_bib219","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0165-0173(00)00043-6","article-title":"Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide","volume":"34","author":"de la Torre","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.nic.2005.09.009_bib220","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.bbrc.2005.04.057","article-title":"AP-1 mediates \u03b2-amyloid-induced: iNOS expression in PC12 cells via the ERK2 and p38 MAPK signaling pathways","volume":"331","author":"Jang","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nic.2005.09.009_bib221","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jnr.20093","article-title":"Microglia and Alzheimer's disease pathogenesis","volume":"77","author":"Streit","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nic.2005.09.009_bib222","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2174\/1389450043345308","article-title":"Cytokines in neuroinflammation and Alzheimer's disease","volume":"5","author":"Cacquevel","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.nic.2005.09.009_bib223","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/13550289909029743","article-title":"Chemokines\/chemokine receptors in the central nervous system and Alzheimer's disease","volume":"5","author":"Xia","year":"1999","journal-title":"J Neurovirol"},{"key":"10.1016\/j.nic.2005.09.009_bib224","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.neures.2003.11.006","article-title":"Effects of beta-AP peptides on activation of the transcription factor NF-kappaB and in cell proliferation in glial cell cultures","volume":"48","author":"Casal","year":"2004","journal-title":"Neurosci Res"},{"key":"10.1016\/j.nic.2005.09.009_bib225","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0165-5728(98)00226-4","article-title":"A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced","volume":"93","author":"Johnstone","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nic.2005.09.009_bib226","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","article-title":"Complement activation by \u03b2-amyloid in Alzheimer disease","volume":"89","author":"Rogers","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nic.2005.09.009_bib227","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0143-4160(03)00128-3","article-title":"Neuronal and glial calcium signaling in Alzheimer's disease","volume":"34","author":"Mattson","year":"2003","journal-title":"Cell Calcium"},{"key":"10.1016\/j.nic.2005.09.009_bib228","doi-asserted-by":"crossref","first-page":"171","DOI":"10.55782\/ane-2003-1465","article-title":"Dysregulation of calcium in Alzheimer's disease","volume":"63","author":"Brzyska","year":"2003","journal-title":"Acta Neurobiol Exp (Warsz)"},{"key":"10.1016\/j.nic.2005.09.009_bib229","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrn960","article-title":"Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease","volume":"3","author":"LaFerla","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib230","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neuroscience.2003.11.029","article-title":"Presenilin-1 deficiency impairs glutamate-evoked intracellular calcium responses in neurons","volume":"124","author":"Yang","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.nic.2005.09.009_bib231","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/nbdi.2000.0378","article-title":"Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice","volume":"8","author":"Eckert","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nic.2005.09.009_bib232","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/WNL.44.6.1090","article-title":"Electron transport chain defects in Alzheimer's disease brain","volume":"44","author":"Parker","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2005.09.009_bib233","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/jnr.10087","article-title":"Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia?","volume":"66","author":"Blass","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nic.2005.09.009_bib234","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(99)00847-2","article-title":"Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F \u03b2-amyloid precursor protein","volume":"277","author":"Dodart","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.nic.2005.09.009_bib235","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0306-4522(02)00280-4","article-title":"Impaired hypoxic tolerance and altered protein binding of NADH in presymptomatic APP23 transgenic mice","volume":"114","author":"Buchner","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.nic.2005.09.009_bib236","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00023210-200317010-00003","article-title":"The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment","volume":"17","author":"Watson","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nic.2005.09.009_bib237","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.neurobiolaging.2004.09.014","article-title":"Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models","volume":"26","author":"Patel","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nic.2005.09.009_bib238","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1749-6632.2002.tb04817.x","article-title":"Vascular basis of Alzheimer's pathogenesis","volume":"977","author":"de la Torre","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nic.2005.09.009_bib239","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(99)02113-7","article-title":"Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model","volume":"853","author":"Shi","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.nic.2005.09.009_bib240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00001756-199302000-00025","article-title":"Accumulation of the \u03b2 amyloid precursor protein at sites of ischemic injury in rat brain","volume":"4","author":"Kalaria","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.nic.2005.09.009_bib241","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1749-6632.2000.tb06363.x","article-title":"\u03b2 vasoactivity in vivo","volume":"903","author":"Suo","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nic.2005.09.009_bib242","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1523\/JNEUROSCI.23-23-08231.2003","article-title":"Age-dependent impairment of somatosensory response in the amyloid precursor protein 23 transgenic mouse model of Alzheimer's disease","volume":"23","author":"Mueggler","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib243","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","article-title":"Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease","volume":"307","author":"Stokin","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nic.2005.09.009_bib244","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.expneurol.2003.08.018","article-title":"The \u03b2-amyloid-related proteins presenilin 1 and BACE1 are axonally transported to nerve terminals in the brain","volume":"184","author":"Sheng","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib245","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3233\/JAD-2004-6203","article-title":"Mechanisms of cell death in Alzheimer's disease: role of presenilins","volume":"6","author":"Popescu","year":"2004","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nic.2005.09.009_bib246","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1523\/JNEUROSCI.18-23-09629.1998","article-title":"Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path","volume":"18","author":"Buxbaum","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib247","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1523\/JNEUROSCI.23-17-06914.2003","article-title":"DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3","volume":"23","author":"McPhie","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib248","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1172\/JCI22317","article-title":"Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?","volume":"114","author":"Dickson","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nic.2005.09.009_bib249","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1096\/fj.02-0422fje","article-title":"Erratic expression of DNA polymerases by \u03b2-amyloid causes neuronal death","volume":"16","author":"Copani","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.nic.2005.09.009_bib250","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0006-2952(03)00534-3","article-title":"Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease","volume":"66","author":"Eckert","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nic.2005.09.009_bib251","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1523\/JNEUROSCI.16-23-07533.1996","article-title":"Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons","volume":"16","author":"Paradis","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib252","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1385\/JMN:19:3:289","article-title":"Tau neurofibrillary pathology and microtubule stability","volume":"19","author":"Michaelis","year":"2002","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.nic.2005.09.009_bib253","first-page":"325","article-title":"Molecular pathology of Alzheimer neurofibrillary degeneration","volume":"53","author":"Iqbal","year":"1993","journal-title":"Acta Neurobiol Exp (Warsz)"},{"key":"10.1016\/j.nic.2005.09.009_bib254","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1385\/NMM:2:2:151","article-title":"Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease","volume":"2","author":"Terwel","year":"2002","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.nic.2005.09.009_bib255","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00001756-200302100-00020","article-title":"Glycogen synthase kinase-3 beta-mediated tau phosphorylation in cultured cell lines","volume":"14","author":"Lee","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.nic.2005.09.009_bib256","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s004010100435","article-title":"The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease","volume":"103","author":"Leroy","year":"2002","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.nic.2005.09.009_bib257","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-5793(00)02203-1","article-title":"Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain","volume":"485","author":"Bennecib","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nic.2005.09.009_bib258","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/jnen\/63.10.1080","article-title":"Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis","volume":"63","author":"Sontag","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nic.2005.09.009_bib259","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"}],"container-title":["Neuroimaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514905001036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514905001036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:59:25Z","timestamp":1707526765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052514905001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":259,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S1052514905001036"],"URL":"https:\/\/doi.org\/10.1016\/j.nic.2005.09.009","relation":{},"ISSN":["1052-5149"],"issn-type":[{"value":"1052-5149","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}